Wed, Nov 11, 2026

Price 395.34 (+2.99%) holds firmly above 200-day average and trailing stop 312.05. Long-term leader thesis intact. No news to break trend.

Price 254 (+2.10%) remains well above 200-day average and stop 212.58. Long-term leader thesis intact. No news to break trend.

Price 196.55 (+0.63%) holds above 50-day average and stop 190.75. Trend core thesis intact. No news to break trend.

Price 24.15 (+2.46%) holds above opening range low 22.66 and target 25. Breakout thesis intact. No news to break trend.

Price 756.355 (+1.17%) holds above 200-day average 730.38. Long-term book thesis intact. No news to break trend.

Price 51.16 (-3.42%) holds above 50-day average and stop 47.67. Trend core thesis intact. No news to break trend.

Price 142.745 (-0.59%) holds above 200-day average and stop 115.75. Long-term leader thesis intact. No news to break trend.

Price 357.12 (+1.39%) holds above 200-day average and stop 300.25. Long-term leader thesis intact. No news to break trend.

MPC is in a short-term downtrend (below SMA20/50, RSI 37.7) and faced a BMO price target cut ($535 to $450). However, as a LONG-TERM BOOK position, the rules dictate holding until a weekly close below the 200-day average ($298.25) or news that breaks the long-term thesis. The current price (~$397) is 33% above the 200-day average. The BMO downgrade is a valuation adjustment, not a fundamental break of the long-term case (e.g., margin collapse or regulatory ban). The T1 anomaly was a minor dip absorbed by buyers. The stop of $312.05 remains valid. No new entries are allowed in the closing window.

Price 24.855 is approaching target 25.00. Thesis intact: earnings beat expectation, volume surge. Trailing stop active at ~23.95 (1.28 above entry). Hold for target hit.

VG Q3 earnings and revenues beat estimates, and management raised 2026 profit outlook citing AI power demand. Price broke above the 15-min opening range high (12.49) on 10.6× median volume. Technically, it is above SMA200 (12.82) and SMA50 (13.48) is nearby; 5-day return is +4.13%. The move is supported by a T2 analyst upgrade (Deutsche Bank) and strong volume. Invalidation: Price closes below the opening range low of 12.07.

207 sh @ $12.50 ($2,587.50) · stop $12.07 · target $14.00

GEHC announced Vscan Air AI expansion with Lung Guidance and AutoAS, a catalyst for point-of-care diagnostics. Price broke above the 15-min opening range high (83.42) on 4.6× median volume. Technically, it is 19.3% above its 200-day average (69.9) and 9.25% above SMA20 (76.35), showing a strong uptrend. RSI is 71.6, slightly elevated but not overbought. Invalidation: Price closes below the opening range low of 82.59.

12 sh @ $83.23 ($998.76) · stop $82.59 · target $88.00

The stock is holding above its opening range low (82.59) and the VWAP (82.94) is a minor resistance, but the dip is a healthy pullback in a strong uptrend. The thesis (AI expansion, raised guidance) remains intact. The stop is currently at 82.59, which is the opening range low. Price is at 82.76, so the stop is still valid. No news breaks the trend.

Triggered by our news engine: GEHC -0.79% in 5 min (z -4.21 after removing SPY's move)

KORU is the only setup with a clear, recent catalyst: raised 2026 revenue outlook to $48.0M-$48.5M and beat Q3 EPS/revenue estimates. Price broke above the 15-min opening range high (8.32) on 4.4× median volume. Technically, it is in a strong uptrend (above SMA20/50/200) with a 5-day return of +15.3% following the earnings beat. The opening range low of 8.19 provides a natural, tight stop. The move is supported by strong volume and a clear fundamental catalyst.

4 sh @ $8.36 ($33.44) · stop $8.19 · target $9.50

PSX remains in a long-term uptrend, trading 25.9% above its 200-day average (203.59). Although it is below the 50-day (268.48) and 20-day (273.45) averages, the long-term thesis is intact. No news has broken the long-term case. The position is up 2.92% with a wide stop (212.58) consistent with the long-term book strategy. I will hold.

KORU is up 19.35% today on a confirmed earnings beat and raised 2026 revenue outlook ($48.0M-$48.5M). Price is well above the opening range low (8.19) and the stated stop (8.43), confirming the thesis remains intact. The move is supported by heavy volume (4.4× median) and a strong uptrend. No news contradicts the outlook, and the position is still below the 9.5 target. I will hold through the close to capture further upside toward the target.

SCHE broke above its 15-min opening range high (35.15) on 15.5× median volume, closing at 35.21. This is a strong technical breakout with heavy volume. No recent news in our feeds, so the move is purely technical/flow-driven. The setup is strong enough to warrant a trade based on momentum and volume. Entry: 35.21. Stop: 34.50 (below the opening range low of 35.09 and providing a ~2% risk). Target: 38.00 (approx 8% upside, R:R ~4:1).

28 sh @ $35.22 ($986.16) · stop $34.50 · target $38.00

KORU surged +23% on earnings beat and raised 2026 guidance. Price is well above the original stop. Trail the stop to lock in gains while leaving room for the 9.50 target.

4 sh @ $8.88 · stop $8.63 · target $9.50

KRMN closed at 44.03, breaking above its 15-min opening range high of 43.74 on 6.5× median volume. Technically, it is in a strong short-term uptrend (above SMA20/50) with a 5-day return of +28.87% and RSI 60.6. The move is supported by heavy volume and a clear technical breakout. Invalidation: Price closes below the opening range low of 43.39.

59 sh @ $44.04 ($2,598.36) · stop $43.39 · target $48.00

ABT broke above its 15-min opening range high (110.04) on 2.2× median volume, closing at 110.17. The move is supported by a T2 catalyst: FDA approval and CE Mark for a new implantable cardioverter-defibrillator lead (Nov 11, 6:33 AM ET). Technically, ABT is in a strong uptrend (above SMA20/50/200) with RSI 58.4 and room to the 52-week high (132.03). The opening range low (109.1) provides a natural stop. Target 115.0 offers ~4.4% upside vs ~1% risk.

1 sh @ $110.12 ($110.12) · stop $109.10 · target $115.00

VLO is a long-term book position held above its 200-day average (292.81). The thesis requires holding until a weekly close below the 200-day average or bearish news. Price (362.92) is well above the 200-day average and recovering from the 20-day range low (342). No news breaks the long-term case. The stop at 300.25 remains valid.

U is in the TREND CORE, managed by rules that trail the stop and sell on a close below the 50-day average. The current price of 49.625 is above the trailing stop at 47.67. The trend remains intact with no news to break the long-term case. The recent -3% move is within normal volatility and does not invalidate the thesis. The stop remains at 47.67, which is below the 50-day average (42.99) and provides a buffer against further downside. No action needed at this time.